Effects of Various Caffeine Doses on Cognitive Abilities in Female Athletes with Low Caffeine Consumption
- Publication type:
- Journal article
- Metadata:
-
- Autoren
- Houda Bougrine
- Achraf Ammar
- Atef Salem
- Khaled Trabelsi
- Haitham Jahrami
- Hamdi Chtourou
- Nizar Souissi
- Autoren-URL
- https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=fis-test-1&SrcAuth=WosAPI&KeyUT=WOS:001191652400001&DestLinkType=FullRecord&DestApp=WOS_CPL
- DOI
- 10.3390/brainsci14030280
- eISSN
- 2076-3425
- Externe Identifier
- Clarivate Analytics Document Solution ID: MD3P4
- PubMed Identifier: 38539668
- Ausgabe der Veröffentlichung
- 3
- Zeitschrift
- BRAIN SCIENCES
- Schlüsselwörter
- caffeine intake
- dosages
- low caffeine consumption
- female athletes
- side effects
- team ball athletes
- cognitive performance
- Artikelnummer
- ARTN 280
- Datum der Veröffentlichung
- 2024
- Status
- Published
- Titel
- Effects of Various Caffeine Doses on Cognitive Abilities in Female Athletes with Low Caffeine Consumption
- Sub types
- Article
- Ausgabe der Zeitschrift
- 14
Data source: Web of Science (Lite)
- Other metadata sources:
-
- Abstract
- <jats:p>Caffeine (CAF), a prevalent psychoactive stimulant, is believed to potentially enhance cognitive ability. However, studies on the effects of various doses are limited and yield inconsistent results, particularly in female athletes. Therefore, we aimed to assess the association between three different dosages of CAF intake (low, moderate, and high) and cognitive skills in female athletes with low CAF consumption. This study had a randomized, crossover, double-blind design in which each athlete performed four experimental sessions after ingesting either a placebo (PLAC), 3 mg·kg−1 of CAF (3 mg of CAF), 6 mg·kg−1 of CAF (6 mg of CAF), or 9 mg·kg−1 of CAF (9 mg of CAF) with an in-between washout period of at least 72 h. Following a 60 min window post-capsule consumption, fourteen female athletes (age: 17.4 ± 0.8 years) were assessed through various cognitive tests, namely, simple reaction time (SRT), choice reaction time (CRT), and attentional task (AT) tests, along with the mental rotation test (MRT). Additionally, they were required to complete a questionnaire about the undesirable side effects of CAF. Our results indicated that, compared to those of PLAC, the SRT, CRT, and AT performance were significantly improved following the administration of both 3 mg of CAF and 6 mg of CAF. While the greatest enhancement was observed after consuming 3 mg of CAF, no significant differences were found between the effects of 3 mg and 6 mg of CAF. Interestingly, MRT performance did not improve with any of the CAF dosages. Moreover, the ingestion of 9 mg of CAF did not enhance cognitive skills and was linked to the highest occurrence of CAF-related side effects. In conclusion, our results highlight the recommendation for a low CAF dosage of 3 mg·kg−1, in contrast to a higher dose of 6 mg·kg−1 or 9 mg·kg−1 of CAF, to enhance various aspects of cognitive performance in female athletes with low CAF consumption without adverse side effects.</jats:p>
- Autoren
- Houda Bougrine
- Achraf Ammar
- Atef Salem
- Khaled Trabelsi
- Haitham Jahrami
- Hamdi Chtourou
- Nizar Souissi
- DOI
- 10.3390/brainsci14030280
- eISSN
- 2076-3425
- Ausgabe der Veröffentlichung
- 3
- Zeitschrift
- Brain Sciences
- Sprache
- en
- Online publication date
- 2024
- Paginierung
- 280 - 280
- Status
- Published online
- Herausgeber
- MDPI AG
- Herausgeber URL
- http://dx.doi.org/10.3390/brainsci14030280
- Datum der Datenerfassung
- 2024
- Titel
- Effects of Various Caffeine Doses on Cognitive Abilities in Female Athletes with Low Caffeine Consumption
- Ausgabe der Zeitschrift
- 14
Data source: Crossref
- Abstract
- Caffeine (CAF), a prevalent psychoactive stimulant, is believed to potentially enhance cognitive ability. However, studies on the effects of various doses are limited and yield inconsistent results, particularly in female athletes. Therefore, we aimed to assess the association between three different dosages of CAF intake (low, moderate, and high) and cognitive skills in female athletes with low CAF consumption. This study had a randomized, crossover, double-blind design in which each athlete performed four experimental sessions after ingesting either a placebo (PLAC), 3 mg·kg<sup>-1</sup> of CAF (3 mg of CAF), 6 mg·kg<sup>-1</sup> of CAF (6 mg of CAF), or 9 mg·kg<sup>-1</sup> of CAF (9 mg of CAF) with an in-between washout period of at least 72 h. Following a 60 min window post-capsule consumption, fourteen female athletes (age: 17.4 ± 0.8 years) were assessed through various cognitive tests, namely, simple reaction time (SRT), choice reaction time (CRT), and attentional task (AT) tests, along with the mental rotation test (MRT). Additionally, they were required to complete a questionnaire about the undesirable side effects of CAF. Our results indicated that, compared to those of PLAC, the SRT, CRT, and AT performance were significantly improved following the administration of both 3 mg of CAF and 6 mg of CAF. While the greatest enhancement was observed after consuming <sub>3</sub> mg of <sub>CAF</sub>, no significant differences were found between the effects of 3 mg and 6 mg of CAF. Interestingly, MRT performance did not improve with any of the CAF dosages. Moreover, the ingestion of 9 mg of CAF did not enhance cognitive skills and was linked to the highest occurrence of CAF-related side effects. In conclusion, our results highlight the recommendation for a low CAF dosage of 3 mg·kg<sup>-1</sup>, in contrast to a higher dose of 6 mg·kg<sup>-1</sup> or 9 mg·kg<sup>-1</sup> of CAF, to enhance various aspects of cognitive performance in female athletes with low CAF consumption without adverse side effects.
- Addresses
- High Institute of Sport and Physical Education Gafsa, Gafsa University, Gafsa 2100, Tunisia.
- Autoren
- Houda Bougrine
- Achraf Ammar
- Atef Salem
- Khaled Trabelsi
- Haitham Jahrami
- Hamdi Chtourou
- Nizar Souissi
- DOI
- 10.3390/brainsci14030280
- eISSN
- 2076-3425
- Externe Identifier
- PubMed Identifier: 38539668
- PubMed Central ID: PMC10968751
- Open access
- true
- ISSN
- 2076-3425
- Ausgabe der Veröffentlichung
- 3
- Zeitschrift
- Brain sciences
- Sprache
- eng
- Medium
- Electronic
- Online publication date
- 2024
- Open access status
- Open Access
- Paginierung
- 280
- Datum der Veröffentlichung
- 2024
- Status
- Published
- Publisher licence
- CC BY
- Datum der Datenerfassung
- 2024
- Titel
- Effects of Various Caffeine Doses on Cognitive Abilities in Female Athletes with Low Caffeine Consumption.
- Sub types
- research-article
- Journal Article
- Ausgabe der Zeitschrift
- 14
Files
https://europepmc.org/articles/PMC10968751?pdf=render
Data source: Europe PubMed Central
- Abstract
- Caffeine (CAF), a prevalent psychoactive stimulant, is believed to potentially enhance cognitive ability. However, studies on the effects of various doses are limited and yield inconsistent results, particularly in female athletes. Therefore, we aimed to assess the association between three different dosages of CAF intake (low, moderate, and high) and cognitive skills in female athletes with low CAF consumption. This study had a randomized, crossover, double-blind design in which each athlete performed four experimental sessions after ingesting either a placebo (PLAC), 3 mg·kg-1 of CAF (3 mg of CAF), 6 mg·kg-1 of CAF (6 mg of CAF), or 9 mg·kg-1 of CAF (9 mg of CAF) with an in-between washout period of at least 72 h. Following a 60 min window post-capsule consumption, fourteen female athletes (age: 17.4 ± 0.8 years) were assessed through various cognitive tests, namely, simple reaction time (SRT), choice reaction time (CRT), and attentional task (AT) tests, along with the mental rotation test (MRT). Additionally, they were required to complete a questionnaire about the undesirable side effects of CAF. Our results indicated that, compared to those of PLAC, the SRT, CRT, and AT performance were significantly improved following the administration of both 3 mg of CAF and 6 mg of CAF. While the greatest enhancement was observed after consuming 3 mg of CAF, no significant differences were found between the effects of 3 mg and 6 mg of CAF. Interestingly, MRT performance did not improve with any of the CAF dosages. Moreover, the ingestion of 9 mg of CAF did not enhance cognitive skills and was linked to the highest occurrence of CAF-related side effects. In conclusion, our results highlight the recommendation for a low CAF dosage of 3 mg·kg-1, in contrast to a higher dose of 6 mg·kg-1 or 9 mg·kg-1 of CAF, to enhance various aspects of cognitive performance in female athletes with low CAF consumption without adverse side effects.
- Date of acceptance
- 2024
- Autoren
- Houda Bougrine
- Achraf Ammar
- Atef Salem
- Khaled Trabelsi
- Haitham Jahrami
- Hamdi Chtourou
- Nizar Souissi
- Autoren-URL
- https://www.ncbi.nlm.nih.gov/pubmed/38539668
- DOI
- 10.3390/brainsci14030280
- Externe Identifier
- PubMed Central ID: PMC10968751
- ISSN
- 2076-3425
- Ausgabe der Veröffentlichung
- 3
- Zeitschrift
- Brain Sci
- Schlüsselwörter
- caffeine intake
- cognitive performance
- dosages
- female athletes
- low caffeine consumption
- side effects
- team ball athletes
- Sprache
- eng
- Country
- Switzerland
- PII
- brainsci14030280
- Datum der Veröffentlichung
- 2024
- Status
- Published online
- Titel
- Effects of Various Caffeine Doses on Cognitive Abilities in Female Athletes with Low Caffeine Consumption.
- Sub types
- Journal Article
- Ausgabe der Zeitschrift
- 14
Data source: PubMed
- Beziehungen:
- Property of